NCT06031194View on ClinicalTrials.gov

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions
Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER